Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Stay Informed: Medical and Research Updates
Connect With Us!


Drug That Blocks Blood Pressure Protein Protected Mice from Developing Glaucoma

March 8, 2011

First of Many Glaucoma Genes Identified by Cluster Search Method

Findings: BrightFocus-supported researchers from The Jackson Laboratory have used a new cluster method to identify genes that have activity changes during the early stages of glaucoma. One of these changes to a blood pressure protein called endothelin 2 can be blocked by the FDA-approved drug, Bosentan. This drug is already used to treat pulmonary hypertension and chronic heart failure in humans. It now appears to protect mice from developing visible damage to their retina due to glaucoma.

Relevance: If proven effective in further laboratory and human clinical testing, this new Bosentan treatment could potentially prevent eye damage and vision loss due to glaucoma. The other early-stage glaucoma gene changes identified by these researchers will be made available to the worldwide scientific community through a new database.

On behalf of our donors, National Glaucoma Research—a program of the BrightFocus Foundation—salutes grantees Drs. Gareth Howell and Simon John for this important work.

Co-authors Drs. Jeffrey Marchant and Ben Barres are former BrightFocus grantees. Dr. Abbot Clark serves as a scientific advisor to BrightFocus.


View all news updates for glaucoma

Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.

Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.

YouTube Twitter YouTube Shop for a Cause Connect With Us Pinterest Google+